Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

FDA approves Gensia's injectable acyclovir

Aug. 29, 1997

Faulding's generic acyclovir receives FDA approval

Aug. 29, 1997

Marketing agreement reached for Abelcet in France and Italy

Aug. 28, 1997

BMS reports new cephalosporins active against MRSA

Aug. 28, 1997

Data sheet for Lariam updated

Aug. 27, 1997

RespiGam approved for marketing in Canada

Aug. 25, 1997

Supplemental NDA approved for Cipro

Aug. 22, 1997

Chlorhexidine solution prevents perinatal infections

Aug. 22, 1997

GT35 described in patent literature by Kyowa Hakko

Aug. 20, 1997

Positive phase III results for Lidakol in oral herpes

Aug. 19, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...